CRISPR gene therapy seems to cure dangerous inflammatory condition
A groundbreaking new approach shows promise in treating a rare genetic condition known as hereditary angioedema. This innovative therapy, utilizing CRISPR technology, targets the gene responsible for kallikrein, a protein linked to inflammation. In a trial involving nine individuals afflicted with this debilitating condition, results have been nothing short of astounding. Participants experienced a […]